Results 31 to 40 of about 563,198 (309)

Prolonged P‐wave duration in sinus rhythm pre‐ablation is associated with atrial fibrillation recurrence after pulmonary vein isolation—A systematic review and meta‐analysis

Annals of Noninvasive Electrocardiology, 2019
A prolonged P‐wave duration (PWD) in sinus rhythm pre‐ablation has been hypothesized to be a non‐invasive ECG marker associated with increased atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI).
R. Pranata, E. Yonas, R. Vania
semanticscholar   +1 more source

Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study

European Heart Journal
Background and Aims In patients with atrial fibrillation (AF), recurrent AF and sinus rhythm during follow-up are determined by interactions between cardiovascular disease processes and rhythm control therapy.
Larissa Fabritz, C. Al-Taie, K. Borof, Günter Breithardt, A. Camm, H. Crijns, Victor Roth Cardoso, W. Chua, Silke van Elferen, Lars Eckardt, George Gkoutos, A. Goette, E. Guasch, S. Hatem, A. Metzner, L. Mont, Vaishnavi Ameya Murukutla, J. Obergassel, A. Rillig, Mortiz Sinner, Renate B. Schnabel, U. Schotten, L. Sommerfeld, U. Wienhues‐Thelen, A. Zapf, Tanja Zeller, P. Kirchhof   +26 more
semanticscholar   +1 more source

Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction

European Journal of Heart Failure, 2019
To assess the association between atrial fibrillation (AF) and mortality, and also the association between resting heart rate (HR) and mortality in both sinus rhythm (SR) and AF in patients with heart failure with preserved ejection fraction (HFpEF).
U. Sartipy, G. Savarese, U. Dahlström, M. Fu, L. Lund   +4 more
semanticscholar   +1 more source

Surgical Treatment of Atrial Fibrillation in Patients with Rheumatic Valve Disease

Brazilian Journal of Cardiovascular Surgery
Objective: To assess heart rhythm and predictive factors associated with sinus rhythm after one year in patients with rheumatic valve disease undergoing concomitant surgical treatment of atrial fibrillation.
Ernesto Koehler Chavez, Alexandre Siciliano Colafranceschi, Andrey José de Oliveira Monteiro, Leonardo Secchin Canale, Evandro Tinoco Mesquita, Clara Weksler, Odilon Nogueira Barbosa, Anderson Oliveira   +7 more
doaj   +1 more source

Cardioverting acute atrial fibrillation and the risk of thromboembolism: not all patients are created equal [PDF]

, 2017
Current guidelines support the well-established clinical practice that patients who present with atrial fibrillation (AF) of less than 48 hours duration should be considered for cardioversion, even in the absence of pre-existing anticoagulation. However,
Rankin, Alastair J., Rankin, Stephen H.
core   +1 more source

Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis

Heart, 2019
Objective Heart failure is a prothrombotic state, and it has been hypothesised that thrombosis and embolism cause non-fatal and fatal events in heart failure and reduced ejection fraction (HFrEF).
S. Beggs, R. Rørth, R. Gardner, J. McMurray   +3 more
semanticscholar   +1 more source

Esophageal Electrical Cardioversion of Atrial Fibrillation: When Esophagus Gives a Help to Cardiologists

Cardiology Research and Practice, 2011
Atrial fibrillation is a common clinical disease especially in the elderly and in patients with organic heart disease. Electrical cardioversion is the first choice therapeutic approach for patients in which sinus rhythm could improve the quality of life
Luca Santini, Giovanni B. Forleo, Francesco Romeo   +2 more
doaj   +1 more source

Efficacy and Safety of Bepridil for Patients with Persistent Atrial Fibrillation after Failed Electrical Cardioversion

Journal of Arrhythmia, 2011
Introduction: Bepridil is effective for atrial fibrillation (AF), but it can induce torsades de pointes. Thus we examined the efficacy and safety of bepridil when started at 100 mg/day for AF after failed electrical cardioversion (EC).
Yasuyuki Egami, MD, Masami Nishino, MD, Masayuki Taniike, MD, Nobuhiko Makino, MD, Hiroyasu Kato, MD, Ryu Shutta, MD, Jun Tanouchi, MD, Yoshio Yamada, MD   +7 more
doaj   +1 more source

A case report of cardiogenic syncope in the adolescent.

Medičnì Perspektivi, 2018
The article presents authors’ observation of a clinical case of the girl aged 15 years old with cardiogenic syncope due to sick sinus syndrome, which progressed from normocardia sinus rhythm to pauses of the cardiac rhythm lasting 10.2-second during 3 ...
O. I. Gayduk, S. G. Ivanus', T. A. Gayduk, I. I. Shvirid, L. N. Kramarenko, T. V. Baralej   +5 more
doaj   +1 more source

Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction

European Journal of Heart Failure, 2019
To investigate the relationship between heart rate and outcomes in heart failure and reduced ejection fraction (HFrEF) patients in sinus rhythm (SR) and atrial fibrillation (AF) adjusting for natriuretic peptide concentration, a powerful prognosticator.
K. Docherty, Li Shen, D. Castagno, M. Petrie, W. Abraham, M. Böhm, Akshay S. Desai, K. Dickstein, L. Køber, M. Packer, J. Rouleau, S. Solomon, K. Swedberg, A. Vazir, M. Zile, P. Jhund, J. McMurray   +16 more
semanticscholar   +1 more source